These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 21711705)
1. Promotion of allergic immune responses by intranasally-administrated nanosilica particles in mice. Yoshida T; Yoshioka Y; Fujimura M; Yamashita K; Higashisaka K; Morishita Y; Kayamuro H; Nabeshi H; Nagano K; Abe Y; Kamada H; Tsunoda S; Itoh N; Yoshikawa T; Tsutsumi Y Nanoscale Res Lett; 2011 Mar; 6(1):195. PubMed ID: 21711705 [TBL] [Abstract][Full Text] [Related]
2. Intranasal exposure to amorphous nanosilica particles could activate intrinsic coagulation cascade and platelets in mice. Yoshida T; Yoshioka Y; Tochigi S; Hirai T; Uji M; Ichihashi K; Nagano K; Abe Y; Kamada H; Tsunoda S; Nabeshi H; Higashisaka K; Yoshikawa T; Tsutsumi Y Part Fibre Toxicol; 2013 Aug; 10():41. PubMed ID: 23958113 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles. Toda T; Yoshino S Int J Immunopathol Pharmacol; 2016 Sep; 29(3):408-20. PubMed ID: 27343242 [TBL] [Abstract][Full Text] [Related]
4. Amorphous nanosilica particles block induction of oral tolerance in mice. Toda T; Yoshino S J Immunotoxicol; 2016 Sep; 13(5):723-8. PubMed ID: 27086695 [TBL] [Abstract][Full Text] [Related]
5. Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. Nygaard UC; Hansen JS; Samuelsen M; Alberg T; Marioara CD; Løvik M Toxicol Sci; 2009 May; 109(1):113-23. PubMed ID: 19293371 [TBL] [Abstract][Full Text] [Related]
6. Suppression of nanosilica particle-induced inflammation by surface modification of the particles. Morishige T; Yoshioka Y; Inakura H; Tanabe A; Narimatsu S; Yao X; Monobe Y; Imazawa T; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S Arch Toxicol; 2012 Aug; 86(8):1297-307. PubMed ID: 22418595 [TBL] [Abstract][Full Text] [Related]
7. Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in mice. de Haar C; Hassing I; Bol M; Bleumink R; Pieters R Clin Exp Allergy; 2006 Nov; 36(11):1469-79. PubMed ID: 17083358 [TBL] [Abstract][Full Text] [Related]
8. Iron oxide particles modulate the ovalbumin-induced Th2 immune response in mice. Ban M; Langonné I; Huguet N; Guichard Y; Goutet M Toxicol Lett; 2013 Jan; 216(1):31-9. PubMed ID: 23147377 [TBL] [Abstract][Full Text] [Related]
9. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities. Chisholm D; Libet L; Hayashi T; Horner AA J Allergy Clin Immunol; 2004 Mar; 113(3):448-54. PubMed ID: 15007346 [TBL] [Abstract][Full Text] [Related]
14. The allergy adjuvant effect of particles - genetic factors influence antibody and cytokine responses. Nygaard UC; Aase A; Løvik M BMC Immunol; 2005 Jun; 6():11. PubMed ID: 15967044 [TBL] [Abstract][Full Text] [Related]
15. Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma. Moerch U; Haahr Hansen M; Vest Hansen NJ; Rasmussen LK; Oleksiewicz MB; Frandsen TP; Haurum JS; Bregenholt S Int Arch Allergy Immunol; 2006; 140(3):261-9. PubMed ID: 16699287 [TBL] [Abstract][Full Text] [Related]
16. Mice vaccinated with allergen-pulsed myeloid dendritic cells are not protected from developing allergen-induced Th2 responses. Trujillo-Vargas CM; Ramirez-Pineda JR; Palmetshofer A; Grunewald S; Moll H; Berberich C; Erb KJ Int Arch Allergy Immunol; 2005 Jul; 137(3):219-28. PubMed ID: 15956790 [TBL] [Abstract][Full Text] [Related]
17. Yan-Hou-Qing formula attenuates allergic airway inflammation via up-regulation of Treg and suppressing Th2 responses in Ovalbumin-induced asthmatic mice. Cheng BH; Hu TY; Mo LH; Ma L; Hu WH; Li YS; Liu ZQ; Qiu SQ J Ethnopharmacol; 2019 Mar; 231():275-282. PubMed ID: 30496840 [TBL] [Abstract][Full Text] [Related]
18. Allergen-specific regulation of allergic rhinitis in mice by intranasal exposure to IgG1 monoclonal antibody Fab fragments against pathogenic allergen. Matsuoka D; Mizutani N; Sae-Wong C; Yoshino S Immunol Lett; 2014 Sep; 161(1):149-56. PubMed ID: 24954639 [TBL] [Abstract][Full Text] [Related]
19. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses. Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081 [TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of IL-33 and IL-25 in an ovalbumin-induced allergic rhinitis mouse model. Yang C; Chen N; Tang XL; Qian XH; Cai CP J Biol Regul Homeost Agents; 2021; 35(2):571-581. PubMed ID: 33738997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]